regulatory
confidence high
sentiment positive
materiality 0.70
P3 Health Partners regains Nasdaq compliance on Listing Rule 5550(b)(2)
P3 Health Partners Inc.
- Received Nasdaq letter on May 20, 2026 confirming compliance with continued listing standards.
- Compliance determination based on Company's Form 8-K filed May 15, 2026.
- Previously disclosed non-compliance with Nasdaq Listing Rule 5550(b) on November 28, 2025.
- Company now satisfies the $35 million market value of listed securities requirement under Rule 5550(b)(2).